<DOC>
	<DOCNO>NCT00864968</DOCNO>
	<brief_summary>The purpose study evaluate relative bioavailability nabumetone 2 tablet product determine 2 product bioequivalent .</brief_summary>
	<brief_title>Single Dose Two-Way Crossover Fasted Bioequivalence Study Nabumetone 750 mg Tablets Healthy Volunteers</brief_title>
	<detailed_description>Study Type : Interventional Study Design : Randomized , 2-period , 2-sequence , crossover design . Official Title : Single Dose Two-Way Crossover Fasted Bioequivalence Study Nabumetone 750 mg Tablets Healthy Volunteers Further study detail provide Actavis Elizabeth LLC : Primary Outcome Measures : Rate Extend Absorption</detailed_description>
	<mesh_term>Nabumetone</mesh_term>
	<criteria>Inclusion Criteria 1 . Healthy subject least 18 year age . 2 . Availability subject entire study period willingness provide write informed consent inform nature study . 3 . Body mass index ( BMI ) 18 30 kg/m2 ( calculate use BMI Calculator Centers Disease Control Prevention [ CDC ] website available http : //www.cdc.gov/nccdphp/dnpa/bmi/index.htm , last access 19 Mar 07 ) weight least 110 pound . 4 . Good health determine lack clinically significant abnormality health assessment perform Screening , judge physician . 5 . Females require use medically acceptable method hormonal contraception abstinence throughout entire study period one week study complete Exclusion Criteria 1 . Hypersensitivity nabumetone ( Nabumetone ) relate compound . 2 . Conditions affect absorption , metabolism , passage drug body ( eg , sprue , celiac disease , Crohn 's disease , colitis , liver , kidney , thyroid condition ) . 3 . Recent history ( within 1 year ) mental illness , drug addiction , drug abuse , alcoholism . 4 . A hematocrit value ≤ 33.0 % female ≤ 37.0 % male . 5 . Donation &gt; 500 mL blood past 8 week prior study drug dose difficulty donate blood . 6 . Receipt investigational drug within 4 week prior study drug dosing . 7 . Currently take systemic prescription medication , exclude hormone contraceptive , within 7 day prior study dose overthecounter medication within 3 day study dose . This prohibition include vitamin herbal preparation take nutritional supplement nontherapeutic indication , judge attend physician . Any nonprescription medication consumption report reviewed investigator prior dose . At discretion investigator , volunteer could enrol medication anticipate alter study integrity . 8 . Regular smoke 5 cigarette weekly regular daily use nicotinecontaining product begin 3 month study drug administration final evaluation . 9 . Female subject lactate positive pregnancy test Screening prior treatment period . 10 . Alcohol , grapefruit beverage food , caffeine , xanthine beverage food begin 48 hour study drug administration last pharmacokinetic ( PK ) sample treatment period . Such restricted item include coffee , tea , iced tea , Coke® , Pepsi® , Mountain Dew® , chocolate , brownie , etc . 11 . Regular use drug know induce inhibit hepatic drug metabolism ( example include barbiturate , carbamazepine , rifampin , phenylhydantoins , phenothiazine , cimetidine , omeprazole , macrolides , imidazole , fluoroquinolones ) within 30 day prior study drug administration . 12 . Positive test result human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody Screening . 13 . Positive test result drug abuse pregnancy Screening prior study drug dosing period . Any deviation inclusion exclusion criterion must approve investigator and/or sponsor casebycase basis prior enrollment subject . The protocol deviation waiver must document investigator and/or sponsor . No subject allow enroll study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Nabumetone</keyword>
	<keyword>Healthy subject</keyword>
</DOC>